Onco-immunological Aspect of COVID-19: Current Progress and Perceptions | Bentham Science
Login Register Cart 0
Generic placeholder image

Coronaviruses

Editor-in-Chief

ISSN (Print): 2666-7967
ISSN (Online): 2666-7975

Back
Journal Home About Journal Editorial Board Current Issue Volumes/Issues
Subscribe
Editorial

Onco-immunological Aspect of COVID-19: Current Progress and Perceptions

Author(s): Suman Kumar Ray and Sukhes Mukherjee*

Volume 3, Issue 2, 2022

Published on: 01 February, 2022

Article ID: e280122200095 Pages: 3

DOI: 10.2174/2666796703666220107122907

Open Access Journals Promotions 2
[1]
Stroppa EM, Toscani I, Citterio C, et al. Coronavirus disease-2019 in cancer patients. A report of the first 25 cancer patients in a western country (Italy). Future Oncol 2020; 16(20): 1425-32.
[http://dx.doi.org/10.2217/fon-2020-0369] [PMID: 32403946]
[2]
Florindo HF, Kleiner R, Vaskovich-Koubi D, et al. Immune-mediated approaches against COVID-19. Nat Nanotechnol 2020; 15(8): 630-45.
[http://dx.doi.org/10.1038/s41565-020-0732-3] [PMID: 32661375]
[3]
Tang Y, Liu J, Zhang D, Xu Z, Ji J, Wen C. Cytokine storm in COVID-19: The current evidence and treatment strategies. Front Immunol 2020; 11: 1708.
[http://dx.doi.org/10.3389/fimmu.2020.01708] [PMID: 32754163]
[4]
Mantlo E, Bukreyeva N, Maruyama J, Paessler S, Huang C. Antiviral activities of type I interferons to SARS-CoV-2 infection. Antiviral Res 2020; 179: 104811.
[http://dx.doi.org/10.1016/j.antiviral.2020.104811] [PMID: 32360182]
[5]
Ni Y, Alu A, Lei H, Wang Y, Wu M, Wei X. Immunological perspectives on the pathogenesis, diagnosis, prevention and treatment of COVID-19. Mol Biomed 2021; 2(1): 1.
[http://dx.doi.org/10.1186/s43556-020-00015-y] [PMID: 34766001]
[6]
Ray SK, Mukherjee S. Understanding the role of Corona Virus based on current scientific evidence - A review with emerging importance in pandemic. Recent Pat Antiinfect Drug Discov 2020; 15(2): 89-103.
[http://dx.doi.org/10.2174/1574891X15999200918144833] [PMID: 32957894]
[7]
Strohl WR, Naso M. Bispecific T-Cell redirection versus chimeric antigen receptor (CAR)-T cells as approaches to kill cancer cells. Antibodies (Basel) 2019; 8(3): 41.
[http://dx.doi.org/10.3390/antib8030041] [PMID: 31544847]
[8]
Catanzaro M, Fagiani F, Racchi M, Corsini E, Govoni S, Lanni C. Immune response in COVID-19: addressing a pharmacological challenge by targeting pathways triggered by SARS-CoV-2. Signal Transduct Target Ther 2020; 5(1): 84.
[http://dx.doi.org/10.1038/s41392-020-0191-1] [PMID: 32467561]
[9]
Abbas HA, Wierda WG. Acalabrutinib: A selective bruton tyrosine kinase inhibitor for the treatment of B-cell malignancies. Front Oncol 2021; 11: 668162.
[http://dx.doi.org/10.3389/fonc.2021.668162] [PMID: 34055635]
[10]
Sterne JAC, Murthy S, Diaz JV, et al. WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group. Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19: A meta-analysis. JAMA 2020; 324(13): 1330-41.
[http://dx.doi.org/10.1001/jama.2020.17023] [PMID: 32876694]
[11]
Wang Z, Yang X, Zhong J, et al. Exposure to SARS-CoV-2 generates T-cell memory in the absence of a detectable viral infection. Nat Commun 2021; 12(1): 1724.
[http://dx.doi.org/10.1038/s41467-021-22036-z] [PMID: 33741972]
[12]
Park A, Iwasaki A. Type I and type III interferons - induction, signaling, evasion, and application to combat COVID-19. Cell Host Microbe 2020; 27(6): 870-8.
[http://dx.doi.org/10.1016/j.chom.2020.05.008] [PMID: 32464097]
[13]
Melo AKG, Milby KM, Caparroz ALMA, et al. Biomarkers of cytokine storm as red flags for severe and fatal COVID-19 cases: A living systematic review and meta-analysis. PLoS One 2021; 16(6): e0253894.
[http://dx.doi.org/10.1371/journal.pone.0253894] [PMID: 34185801]
[14]
Derosa L, Melenotte C, Griscelli F, et al. The immuno-oncological challenge of COVID-19. Nat Can 2020; 1: 946-64.
[http://dx.doi.org/10.1038/s43018-020-00122-3]

Rights & Permissions Print Cite
Article Metrics
17
1
Wayfinder Image
Open Access Journals Promotions
World Pneumonia Day
© 2024 Bentham Science Publishers | Privacy Policy